Latest Biovica International News & Updates

See the latest news and media coverage for Biovica. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Biovica International (Biovica)

Developer of blood tests for cancer monitoring

biovica.com
Headquarters
Uppsala, Sweden
Founded year
2009
Company type
Public company
Number of employees
30–50
Industry
Biotechnology & Medical Research

Last updated

Latest news about Biovica International (Biovica)

In short: Biovica reported strong fiscal growth, appointed Theis Kipling as CEO, and expanded its oncology patent protection in Japan and Europe.

Company announcements

Biovica

Biovica granted Japanese patent for TKa in immuno-oncology

The patent covers use of TKa to identify patients likely to benefit from immune checkpoint inhibitor treatment, expanding protection from Europe to Japan.

Unlock all announcements with a

Media coverage

Morningstar

Biovica International AB - Annual Report for The Financial Year 2025/2026...

UPPSALA, SE / ACCESS Newswire / June 30, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Annual Report for the financial year 2025/2026 for Biovica international AB...

Unlock all articles with a

Never miss news about Biovica

Track Biovica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Biovica competitors & trending companies

Browse news for competitors to Biovica and other trending companies.